These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 7782761)

  • 21. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
    Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
    Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques.
    Clerici M; Clark EA; Polacino P; Axberg I; Kuller L; Casey NI; Morton WR; Shearer GM; Benveniste RE
    AIDS; 1994 Oct; 8(10):1391-5. PubMed ID: 7818809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
    Nixon DF; Donahoe SM; Kakimoto WM; Samuel RV; Metzner KJ; Gettie A; Hanke T; Marx PA; Connor RI
    Virology; 2000 Jan; 266(1):203-10. PubMed ID: 10612675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239.
    Evans DT; Bricker JE; Sanford HB; Lang S; Carville A; Richardson BA; Piatak M; Lifson JD; Mansfield KG; Desrosiers RC
    J Virol; 2005 Jun; 79(12):7707-20. PubMed ID: 15919923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive immunization of rhesus macaques against SIV infection and disease.
    Gardner M; Rosenthal A; Jennings M; Yee J; Antipa L; Robinson E
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):843-54. PubMed ID: 7546912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag.
    Chen ZW; Shen L; Miller MD; Ghim SH; Hughes AL; Letvin NL
    J Immunol; 1992 Dec; 149(12):4060-6. PubMed ID: 1460291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus.
    Norley S; Beer B; Binninger-Schinzel D; Cosma C; Kurth R
    Virology; 1996 May; 219(1):195-205. PubMed ID: 8623530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of virus-specific CD4(+) T cells with increases in viral loads in the chronic phase after vaccine-based partial control of primary simian immunodeficiency virus replication in macaques.
    Lun WH; Takeda A; Nakamura H; Kano M; Mori K; Sata T; Nagai Y; Matano T
    J Gen Virol; 2004 Jul; 85(Pt 7):1955-1963. PubMed ID: 15218180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus.
    Smith MO; Heyes MP; Lackner AA
    Lab Invest; 1995 May; 72(5):547-58. PubMed ID: 7745949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
    Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.
    Greenier JL; Miller CJ; Lu D; Dailey PJ; Lü FX; Kunstman KJ; Wolinsky SM; Marthas ML
    J Virol; 2001 Apr; 75(8):3753-65. PubMed ID: 11264364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decline of simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in the peripheral blood of long-term nonprogressing macaques infected with SIVmac32H-J5.
    Geretti AM; Hulskotte EG; Dings ME; van Baalen CA; van Amerongen G; Norley SG; Boers P; Gruters R; Osterhaus AD
    J Infect Dis; 1999 Oct; 180(4):1133-41. PubMed ID: 10479140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo T-lymphocyte activation and transient reduction of viral replication in macaques infected with simian immunodeficiency virus.
    Chen ZW; Shen Y; Zhou D; Simon M; Kou Z; Lee-Parritz D; Shen L; Sehgal P; Letvin NL
    J Virol; 2001 May; 75(10):4713-20. PubMed ID: 11312343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte-tropic simian immunodeficiency virus causes persistent infection in the brains of rhesus monkeys.
    Stephens EB; Liu ZQ; Zhu GW; Adany I; Joag SV; Foresman L; Berman NE; Narayan O
    Virology; 1995 Nov; 213(2):600-14. PubMed ID: 7491784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Boosting of SIV-specific T cell responses in rhesus macaques that resist repeated intravaginal challenge with SIVmac251.
    Shacklett BL; Ling B; Veazey RS; Luckay A; Moretto WJ; Wilkens DT; Hu J; Israel ZR; Nixon DF; Marx PA
    AIDS Res Hum Retroviruses; 2002 Sep; 18(14):1081-8. PubMed ID: 12396459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques.
    Kaur A; Grant RM; Means RE; McClure H; Feinberg M; Johnson RP
    J Virol; 1998 Dec; 72(12):9597-611. PubMed ID: 9811693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys.
    Titti F; Sernicola L; Geraci A; Panzini G; Di Fabio S; Belli R; Monardo F; Borsetti A; Maggiorella MT; Koanga-Mogtomo M; Corrias F; Zamarchi R; Amadori A; Chieco-Bianchi L; Verani P
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2529-39. PubMed ID: 9349474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge.
    Yasutomi Y; Koenig S; Woods RM; Madsen J; Wassef NM; Alving CR; Klein HJ; Nolan TE; Boots LJ; Kessler JA
    J Virol; 1995 Apr; 69(4):2279-84. PubMed ID: 7884874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses.
    Malkevitch NV; Patterson LJ; Aldrich MK; Wu Y; Venzon D; Florese RH; Kalyanaraman VS; Pal R; Lee EM; Zhao J; Cristillo A; Robert-Guroff M
    Virology; 2006 Sep; 353(1):83-98. PubMed ID: 16814356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
    Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA
    Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.